LOTEMAX SM 0.38%
Post-operative Ocular Inflammation & Pain
LaunchedCommercial
Key Facts
Indication
Post-operative Ocular Inflammation & Pain
Phase
Launched
Status
Commercial
Company
About Bausch + Lomb
Bausch + Lomb is a leading, pure-play eye health company with a mission to protect and enhance sight globally. Its strategic separation from Bausch Health in 2022 unlocked its potential to focus on the high-growth dynamics of the vision care market. The company's strength lies in its integrated portfolio across Vision Care, Pharmaceuticals, and Surgical segments, supported by significant R&D in material science and drug delivery. Its strategy is centered on innovation, geographic expansion, and leveraging its trusted brand to capitalize on powerful demographic tailwinds.
View full company profile